279 related articles for article (PubMed ID: 10683861)
1. Serotonin transporter gene polymorphism and antidepressant response.
Kim DK; Lim SW; Lee S; Sohn SE; Kim S; Hahn CG; Carroll BJ
Neuroreport; 2000 Jan; 11(1):215-9. PubMed ID: 10683861
[TBL] [Abstract][Full Text] [Related]
2. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.
Pollock BG; Ferrell RE; Mulsant BH; Mazumdar S; Miller M; Sweet RA; Davis S; Kirshner MA; Houck PR; Stack JA; Reynolds CF; Kupfer DJ
Neuropsychopharmacology; 2000 Nov; 23(5):587-90. PubMed ID: 11027924
[TBL] [Abstract][Full Text] [Related]
3. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.
Yu YW; Tsai SJ; Chen TJ; Lin CH; Hong CJ
Mol Psychiatry; 2002; 7(10):1115-9. PubMed ID: 12476327
[TBL] [Abstract][Full Text] [Related]
4. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
5. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
Yoshida K; Takahashi H; Higuchi H; Kamata M; Ito K; Sato K; Naito S; Shimizu T; Itoh K; Inoue K; Suzuki T; Nemeroff CB
Am J Psychiatry; 2004 Sep; 161(9):1575-80. PubMed ID: 15337646
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
Weizman A; Weizman R
Pharmacogenomics; 2000 Aug; 1(3):335-41. PubMed ID: 11256582
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M
Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976
[TBL] [Abstract][Full Text] [Related]
8. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome.
Rausch JL; Johnson ME; Fei YJ; Li JQ; Shendarkar N; Hobby HM; Ganapathy V; Leibach FH
Biol Psychiatry; 2002 May; 51(9):723-32. PubMed ID: 11983186
[TBL] [Abstract][Full Text] [Related]
9. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
[TBL] [Abstract][Full Text] [Related]
10. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH
Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864
[TBL] [Abstract][Full Text] [Related]
11. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment.
Kirchheiner J; Nickchen K; Sasse J; Bauer M; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Feb; 7(1):48-55. PubMed ID: 16702979
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
[TBL] [Abstract][Full Text] [Related]
13. Promoter prognostication: the serotonin transporter gene and antidepressant response.
Kelsoe JR
Mol Psychiatry; 1998 Nov; 3(6):475-6. PubMed ID: 9857969
[No Abstract] [Full Text] [Related]
14. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.
Mann JJ; Huang YY; Underwood MD; Kassir SA; Oppenheim S; Kelly TM; Dwork AJ; Arango V
Arch Gen Psychiatry; 2000 Aug; 57(8):729-38. PubMed ID: 10920459
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment.
Lee MS; Lee HY; Lee HJ; Ryu SH
Psychiatr Genet; 2004 Jun; 14(2):111-5. PubMed ID: 15167699
[TBL] [Abstract][Full Text] [Related]
16. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
[TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors.
Lotrich FE; Pollock BG; Ferrell RE
Am J Pharmacogenomics; 2001; 1(3):153-64. PubMed ID: 12083964
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of serotonin and dopamine transporters in mental disorders.
Ueno S
J Med Invest; 2003 Feb; 50(1-2):25-31. PubMed ID: 12630565
[TBL] [Abstract][Full Text] [Related]
20. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.
Serretti A; Zanardi R; Rossini D; Cusin C; Lilli R; Smeraldi E
Mol Psychiatry; 2001 Sep; 6(5):586-92. PubMed ID: 11526473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
